Evidence map›Paper›PMID 39768191›Full record

ReviewCells2024

Drew A Gillett, Helene Tigro, Yuan Wang, Zucai Suo

Abstract readReview
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Drew A GillettDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.
Helene TigroDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.ORCID 0009-0005-3416-5887
Yuan WangDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.ORCID 0000-0003-4347-7063
Zucai SuoDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.ORCID 0000-0003-3871-3420

Funding

Florida State University startup fund
6 · The paper itself

Abstract

Fragile X Syndrome (FXS) presents with a constellation of phenotypes, including trouble regulating emotion and aggressive behaviors, disordered sleep, intellectual impairments, and atypical physical development. Genetic study of the X chromosome revealed that substantial repeat expansion of the 5' end of the gene fragile X messenger ribonucleoprotein 1 (

Indexed as

Fragile X Messenger Ribonucleoprotein 1Fragile X SyndromeAnimalsDNA MethylationHumansFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1exosomesextracellular vesiclesFMR1FMRPfragile X messenger ribonucleoproteinfragile X messenger ribonucleoprotein 1fragile X syndromeFXS therapeuticsneuronal development

Identifiers

PMID39768191
PMCPMC11674747

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.